Prothya Biosolutions Belgium
ActiveFrom the official registers: KBO 32 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Prothya Biosolutions Belgium has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show negative equity (-€2.2m) and a net result of -€620,353. Equity has been shrinking by about 6.6% per year since 2019. The computed 12-month bankruptcy probability is 1.2% (low).
Overview
Official details
KBO- Status
- Active since 24-12-1997 Normal situation
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21100and 1 other
- Establishment units
- 2.143.853.913 9255 Buggenhout, since 01-01-1998
- 2.084.867.223 1120 Brussel, since 08-01-1998
- Financial year end
- 31 March
- Peppol
- Reachable
Board and ownership
- Raf De PaepeDaily manager
- Gibbs ThomasDirector · since 16-10-2025
- Nadine JakesDirector · since 16-10-2025
- Auditor
- BDO Bedrijfsrevisoren bv
- Accord Plasma B.V.100%annual accounts 31-03-2026
- Intas Pharmaceuticals Ltdconsolidatesannual accounts 31-03-2026
- Holdings
- Shares in 2 companies Prothya Biosolutions Hungary Korlátolt Felelősségű Társaság and Prothya Biosolutions Netherlands
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.2%
- Turnover
- €109.1m
- Loss
- €620,353
- Equity
- -€2.2m
- Total assets
- €134.4m
- Staff
- 349 FTE
Score breakdownraises riskCapped at 59: negative equityNegative equity -€2.2mLiquidity: current ratio 2.44, cash €527,428, halvedLoss of €620,353, the second in a row (financial year 2026)lowers riskSize: turnover €109.1m, 349 FTE, total assets €134.4m, files consolidated accountsShow the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21). It does better than 7% of them on solvency, 61% on liquidity and 22% on profitability.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 6 accounts on average 19 days before the deadline. In the sector (NACE 21), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (1)
Key points
- Risk: Negative equitydebts exceed assets in financial year 2026 -€2.2m View
- Risk: 3 loss-making years in a rowloss in financial year 2026 -€620,353 View
- Positive: 5th largest company by total assets in the Brussels-Capital Region, Pharmaceuticals sectorin the Checked rankings No. 5 View
- A director leftlatest change 20-05-2026 · 2 in office 1 left View
Comparable companies
These companies have the same main activity as Prothya Biosolutions Belgium: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21100). They are comparable in size and age: total assets between €16m and €713m, founded between 1946 and 2014.
| Company | Total assets | Turnover |
|---|---|---|
| Prothya Biosolutions Belgium Brussel | €134.4m | €109.1m |
| PolyPeptide Braine-l'Alleud | €331.7m | €156.1m |
| N.V. Farmaceutische Laboratoria Trenker Nivelles | €16.1m | €29.0m |
| BePharBel Manufacturing Courcelles | €27.4m | €17.0m |
| BAXALTA BELGIUM MANUFACTURING Lessines | €713.1m | €374.2m |
| Catalent Gosselies Charleroi | €24.2m | €10.0m |
| AJINOMOTO OMNICHEM Wetteren | €476.3m | €468.2m |
Documents
Annual accounts at the NBB
- Annual accounts 2026filed on 06-07-2026
- Consolidated accounts 2026filed on 09-07-2026
- Annual accounts 2024filed on 08-07-2025
- Consolidated accounts 2024filed on 09-07-2025
Acts in the Belgian Official Gazette
- Amendment of the articles · Resignations & appointmentsact of 04-06-2026
- Amendment of the articlesact of 18-12-2025
- Amendment of the articles · Resignations & appointmentsact of 30-10-2025
- Capital & shares · Amendment of the articlesact of 30-10-2025
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Prothya Biosolutions Belgium
- What is the company number of Prothya Biosolutions Belgium?
- The company number of Prothya Biosolutions Belgium is 0462.229.645. The VAT number is the same number with BE in front: BE 0462.229.645.
- Where is Prothya Biosolutions Belgium based?
- The registered office is at de Tyraslaan 109, 1120 Brussel.Company details
- What does Prothya Biosolutions Belgium do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21100).
- What is the legal form of Prothya Biosolutions Belgium?
- The legal form of Prothya Biosolutions Belgium is Private limited company (BV).
- When was Prothya Biosolutions Belgium founded?
- Prothya Biosolutions Belgium was founded on 24-12-1997.
- Is Prothya Biosolutions Belgium still active?
- Yes, Prothya Biosolutions Belgium is an active enterprise in the KBO register.
- How many employees does Prothya Biosolutions Belgium have?
- Prothya Biosolutions Belgium had an average of 349 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
- What is the turnover of Prothya Biosolutions Belgium?
- The turnover of Prothya Biosolutions Belgium was €109.1m in financial year 2026, according to the filed annual accounts.
- Is Prothya Biosolutions Belgium profitable?
- In financial year 2026, Prothya Biosolutions Belgium made a loss of €620,353.
- Where can I find the annual accounts of Prothya Biosolutions Belgium?
- Prothya Biosolutions Belgium filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2026.Annual accounts at the National Bank
Next steps
See how customers, suppliers and banks see your own company and what to improve first.